ArriVent BioPharma Inc. C...
(AVBP)
undefined
undefined%
At close: undefined
26.72
0.49%
After-hours Dec 13, 2024, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 |
Cash & Equivalents | 150.39M | 163.37M | 37.28M |
Short-Term Investments | - | - | - |
Long-Term Investments | - | - | 2.00K |
Other Long-Term Assets | 2.84M | 72.00K | 87.00K |
Receivables | 761.00K | 500.00K | 250.00K |
Inventory | -240.00K | - | - |
Other Current Assets | 9.06M | 156.00K | 29.00K |
Total Current Assets | 159.97M | 182.62M | 42.95M |
Property-Plant & Equipment | 291.00K | 139.00K | - |
Goodwill & Intangibles | - | - | - |
Total Long-Term Assets | 3.13M | 211.00K | 89.00K |
Total Assets | 163.10M | 182.83M | 43.04M |
Account Payables | 4.53M | 3.09M | 293.00K |
Deferred Revenue | - | -1 | - |
Short-Term Debt | 140.00K | 128.00K | - |
Other Current Liabilities | 6.95M | 5.14M | 1.52M |
Total Current Liabilities | 11.62M | 8.36M | 1.82M |
Long-Term Debt | 177.00K | 11.00K | - |
Other Long-Term Liabilities | - | - | - |
Total Long-Term Liabilities | 177.00K | 11.00K | - |
Total Liabilities | 11.80M | 8.37M | 1.82M |
Total Debt | 317.00K | 139.00K | - |
Common Stock | - | 4.00K | 4.00K |
Retained Earnings | -157.84M | -88.51M | -51.61M |
Comprehensive Income | - | -4.00K | -4.00K |
Shareholders Equity | 151.30M | 174.46M | 41.22M |
Total Investments | - | - | 2.00K |